Click on a news to open it
March 2021 – Innosuisse support
GliaPharm receives support from Innosuisse for a project to develop specific cell therapy to treat neurological diseases in collaboration with Universities of Bern and Lausanne.
January 2021 – HEPIA collaboration
GliaPharm receives grant for collaboration with HEPIA to setup a new 3D culture method using brain organoids from mouse and human-derived cells.
September 2020 – European Congress of Neuropsychopharmacology
GliaPharm to present at the European Congress of Neuropsychopharmacology – Symposium on “Beyond the Neurocentric Paradigm: Targeting Astrocytes and Neuroglial Interactions in CNS Disorders”. September 13th 2020.
August 2020 – #FOXG1
GliaPharm to present at the virtual #FOXG1ScienceSymposium on August 17/18. Register here to tune in to hear from all the researchers, industry and more about the path to a cure for #FOXG1. #FOXG1SS2020
August 2020 – LifeSci Symposium
GliaPharm presented at the LifeSci Partners Summer Symposium on August 5th 2020
May 2020 – CHF 2 Million financing
GliaPharm completes a CHF 2 Million financing to advance its drug development program for an orphan neurological disease
January 2019 – Collaboration TRB
GliaPharm announces research collaboration with TRB Chemedica International
January 2019 – BLACKSWAN
GliaPharm receives support from the FOXG1 Research Foundation and the BLACKSWAN Foundation to uncover the metabolic effect of FOXG1 in astrocytes
January 2019 – #HTChallenge!
We made it to the @hellotmrc Global Finals of #HTChallenge! From 4,500 applications we have been named one of the 7 Industrial Biotech track Finalists competing to win at the #HTSummit! Come hear us pitch in Paris on March 14-15.
September 2017 – Cydan Award of the MassChallenge
GliaPharm receives the Cydan Award of the MassChallenge startup Accelerator program in Boston, 2017
May 2017 – Finalist to the MassChallenge
GliaPharm has been selected as a Finalist to the MassChallenge Switzerland 2017 startup contest
May 2017 – Campus Biotech
Une troisieme “start-up” rejoint le Campus Biotech
Article in 24heures and Tribune de Geneve (in French)
January 2017 – laboratory at the Campus Biotech
GliaPharm establishes its laboratory at the Campus Biotech in Geneva, Switzerland
September 2016 -Innosuisse
GliaPharm enters the start-up coaching program of Innosuisse (formerly CTI)
July 2016 – CTI financial
The Swiss Commission for Technology and Innovation (CTI) has granted financial support to the collaboration between GliaPharm and Prof. Magistretti’s laboratory (EPFL)
June 2016 – support from the Foundation Rita Puccini
GliaPharm receives financial support from the Foundation Rita Puccini pour l’Etude de la Sclérose Latérale Amyotrophique